DF-003(Dingfu Biotarget)

N/A

Report date: 2023/07/20 10:01:20

Base Information

Drug NameDF-003(Dingfu Biotarget)
Drug Alias NameDF-003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Tumor necrosis factor receptor superfamily member 9Tumor necrosis factor receptor superfamily member 9 agonists
TargetsTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsSolid tumoursLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesDingfu Biotarget Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesDingfu Biotarget Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A